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Abstract
Purpose—Neuroblastoma is a childhood cancer of the sympathetic nervous system with 
embryonic origins. Previous epidemiologic studies suggest maternal vitamin supplementation 
during pregnancy reduces the risk of neuroblastoma. We hypothesized offspring and maternal 
genetic variants in folate-related and choline-related genes are associated with neuroblastoma and 
modify the effects of maternal intake of folate, choline and folic acid.
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Methods—The Neuroblastoma Epidemiology in North America (NENA) study recruited 563 
affected children and their parents through the Children’s Oncology Group’s Childhood Cancer 
Research Network. We used questionnaires to ascertain pre-pregnancy supplementation and 
estimate usual maternal dietary intake of folate, choline and folic acid. We genotyped 955 genetic 
variants related to folate or choline using DNA extracted from saliva samples and used a log-linear 
model to estimate both child and maternal risk ratios and stratum-specific risk ratios for gene-
environment interactions.
Results—Overall, no maternal or offspring genotypic results met criteria for a false discovery 
rate (FDR) Q-value <0.2. Associations were also null for gene-environment interaction with pre-
pregnancy vitamin supplementation, dietary folic acid and folate. FDR significant gene-choline 
interactions were found for offspring SNPs rs10489810 and rs9966612 located in MTHFD1L and 
TYMS, respectively, with maternal choline dietary intake dichotomized at the first quartile.
Conclusion—These results suggest that variants related to one-carbon metabolism are not 
strongly associated with neuroblastoma. Choline-related variants may play a role; however, the 
functional consequences of the interacting variants are unknown and require independent 
replication.
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Neuroblastoma; genetics; folate; choline; case-parent triad
Introduction
Neuroblastoma is an embryonal tumor of the neural crest portion of the sympathetic nervous 
system and usually presents in children less than 1 year of age [1, 2]. Each year 
approximately 770 children in North America are diagnosed with neuroblastoma, with 
incidence rates slightly higher in males (7.7 per million) than females (6.9 per million) [2–
5]. Familial cases of neuroblastoma have been associated with specific mutations in the 
PHOX2B and ALK genes and among non-familial cases, recent genome-wide association 
(GWA) studies have identified several common variants of interest [6–8].
Due to the embryonic origins of neuroblastoma, pre-pregnancy and early pregnancy 
exposures are crucial for its development. Epidemiologic studies have found evidence of an 
inverse association between maternal prenatal vitamin use and risk of neuroblastoma [9, 10]. 
One study reported a 60% reduction in risk for daily vitamin use in the month before or 
during pregnancy. Although these studies did not indicate which vitamin(s) may underlie the 
association with neuroblastoma, folate and choline may be important. Folate is essential for 
one-carbon metabolism and is important in cell proliferation and differentiation of neural 
crest cells [11, 12]. Choline is also involved in one-carbon metabolism and an essential 
building block for membrane development [13].
Due to the key role of folate and choline in fetal and neuronal development and the 
suggestive epidemiological evidence, we hypothesized that genetically-based alterations in 
the levels of folate and choline during development, acting jointly with maternal nutrition, 
may impact the risk of neuroblastoma. This study is the first to examine the risk of 
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neuroblastoma with maternal and offspring single nucleotide polymorphisms (SNPs) as well 
as gene-environment interactions with maternal folate and choline dietary intake and pre-
pregnancy maternal vitamin supplementation.
Methods
Study sample
The Neuroblastoma Epidemiology in North America (NENA) study used a case-parent triad 
design. Cases were identified from the Childhood Cancer Research Network (CCRN) – a 
registry system of cases maintained by the Children’s Oncology Group (COG) [14]. NENA 
approached families registered in the CCRN registry who agreed to be contacted for future 
research. Eligible cases had a primary diagnosis of neuroblastoma, including 
ganglioneuroblastoma but excluding ganglioneuroma. Cases were diagnosed before 6 years 
of age at a U.S. or Canadian COG institution from December 24, 2007 to July 31, 2013. The 
biologic mother had to be alive and willing to participate. The University of North Carolina 
at Chapel Hill (UNC) Institutional Review Board approved this study.
After the cases were identified through the CCRN, we sent a recruitment packet to 1347 
families and 870 families agreed to enroll. Study materials sent included a consent form, 
questionnaire to be filled out by the mother, an Oragene saliva tube collection kit for the 
parents, and an Oragene saliva sponge/disc kit for the child. If the child was deceased, we 
delayed communication by 15 months after date of death and obtained a previously collected 
blood DNA sample from the COG Neuroblastoma Bio-repository at the Children’s Hospital 
of Philadelphia (CHOP).
Saliva samples were collected for 626 biological mothers, 592 living children, and 525 
biological fathers. Blood samples were obtained for 19 deceased children (Supplemental 
Figure S1). Of the 630 maternal questionnaires received, two did not have a corresponding 
signed consent form and two were incomplete, resulting in 626 completed questionnaires for 
analysis (Figure 1).
Candidate genes and DNA collection
Genes were selected based on their role in the transport and metabolism of folate and 
choline as well as one-carbon metabolism. Since most of the mothers self-identified as 
white, TAGster with the greedy algorithm was used to capture haplotype tagging SNPs 
(minor allele frequency≥5%) that tag SNPs in high linkage disequilibrium (LD; r2≥0.8) for 
Hapmap 3 release III CEU population, located between 20kb upstream to 10kb downstream 
from the gene [15, 16]. The case-parent triad design is not subject to confounding by 
population stratification, thus ancestry-informative markers were not included [17]. A total 
of 693 SNPs in 38 folate-related and 302 SNPs in 19 choline-related genes were selected for 
genotyping.
DNA extraction and amplification was completed by the UNC Biospecimen Processing 
Facility. DNA was extracted using the Perkin-Elmer's Chemagic MSMI magnetic-bead 
extraction robotic system. Saliva samples from parents were collected in DNA Genotek’s 
OGR-500 collection kits. Saliva from the child was also collected by the parents using 
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swabs. DNA quality was assessed with Nanodrop Optical Density and quantitated with 
Applied Biosystems® Taqman® RNase P detection kit. A total of 498 triads, 99 mother-
child dyads, 5 father-child dyads and 27 other sets (mother-father dyads and singleton cases) 
with DNA yields greater than 2 µg were sent for genotyping.
Genotyping was performed by UNC’s Mammalian Genotyping Core Facility using the 
GoldenGate Assay with the Illumina BeadStation 500GX Genetic Analysis System. Allelic 
discrimination was based on allele-specific primer extension followed by ligation.
Genotyping Quality Control
For quality control purposes, a Centre de l'Étude du Polymorphisme Humain family triad 
and blinded duplicates were included on each plate. SNPs with a genotyping call rate less 
than 95% and showing a lack of defined clusters in the raw genetic intensity data were 
excluded (N=119). In total, 599 folate-related SNPs and 277 choline-related SNPs passed 
quality control. We assessed Hardy-Weinberg (HWE) equilibrium among parents who self-
identified as white, using chi-square tests in PLINK (v1.07) and flagged (N=5), but did not 
exclude, SNPs that failed HWE at a false discovery rate (FDR) significance level of <0.2 
[18, 19].
Individuals with genotyping rates <95% or gender discrepancies were excluded (N=36; 
Supplemental Figure S1). Relatedness was confirmed for each triad through measures of 
identity by descent. Triads and individuals with unexpected relatedness were excluded. For 
example, for non-paternity the paternal data was excluded (N=1). A total of 465 triads, 94 
mother-child dyads, 4 father-child dyads and 61 others (13 mother-father dyads and 48 
singletons) passed genetic quality control (Figure 1).
Biological and Clinical Variables
We obtained clinical and biologic characteristics of the tumor, such as tumor genetics and 
stage, from the COG Statistical and Data Center for all cases enrolled in a COG clinical 
protocol except 89 cases who were not enrolled. We used the COG prognostic risk schema 
that defined three prognostic risk-classifications: low-risk, intermediate-risk and high-risk. 
These risk-classifications are based on tumor characteristics, including stage and MYCN 
amplification, ploidy and patient age [20].
Maternal Vitamin Use
We ascertained the current and usual maternal diet during the preceding year using the 
Dietary History Questionnaire, a self-administered semi-quantified food frequency 
questionnaire (FFQ). We assumed maternal usual diet in the last year approximates pre-
pregnancy diet. Completed FFQs were processed in Diet*Calc (version 1.5.0) to derive usual 
nutrient intake per day for the previous year. The nutrient and food group database was 
based on a compilation of national 24-hour dietary recall data from the National Health and 
Nutrition Examination Surveys (NHANES) conducted in 2001–2002, 2003–2004, and 
2005–2006 (http://riskfactor.cancer.gov/dhq2/database). Certain foods not included in the 
original database were added by NENA staff in 100 gram amounts using the USDA 
database, standard release 24.
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Mothers were also questioned about maternal dietary supplementation, including single 
vitamins and prenatal or multivitamin use 1 month pre-pregnancy and within each trimester 
of pregnancy. To aid in recall, an estimated conception date was provided; calculated by 
subtracting gestational age at delivery from infant birthdate. Since we are interested in pre-
pregnancy and early pregnancy exposures, we focused on prenatal vitamin, including 
multivitamin, use 1 month pre-pregnancy.
Diet and Nutrient classification
We excluded questionnaires that reported calories per day below the 5th percentile (N=31; 
<854.47 calories) or above the 97th percentile (N=18; >4508.75 calories) (Figure 1). We 
focused on folate, folic acid and choline for gene-environment interaction. To take into 
account the different bioavailability of food folate and folic acid, dietary folate equivalent 
(DFE) was used to estimate total folate. To explore different dietary cutoffs, nutrients from 
the FFQ were dichotomized at the 25th percentile (<209.70 mg for choline; <389.83 µg 
DFE; and <100.69 µg folic acid) and dichotomized at the current daily recommendation for 
adult women. We used the recommended dietary allowance (RDA) for folate of 600 µg DFE 
for pregnant women [21]. Additionally, the Public Health Service Task Force recommends 
used 400 µg folic acid/day for prevention of birth defects for women trying to get pregnant 
[22]. We used the choline Adequate Intake of 425 mg/day for women [23].
We conducted an analysis combining prenatal vitamin use and folic acid and folate from 
diet. Maternal total exposure was dichotomized as low intake and sufficient intake. Women 
with intake in the lowest tertile of micronutrients from diet and with no prenatal 
supplementation 1 month pre-pregnancy were defined as “low intake”. Women were 
classified as “sufficient intake” otherwise. We only combined vitamin use with folic acid and 
folate from diet since choline is not commonly found in prenatal vitamins [24].
Statistical Analysis
There were three main analytic goals: 1) estimate the genotypic maternal and offspring risk 
ratios (RRs); 2) estimate stratum-specific RRs by neuroblastoma prognostic risk-
classification and offspring age at diagnosis; and 3) assess multiplicative maternal and 
offspring gene-environment interactions with maternal choline, folate and folic acid intake. 
We used a log-linear model to simultaneously assess the offspring and maternal log-additive 
genetic main effects and gene-environment interaction [25].
Since there are no study controls in this analysis, the null background is discerned from the 
parental genotypes under the assumption of Mendelian transmission in the source population 
[26]. For assessing a maternally-mediated genetic association, the maternal genotype 
frequencies are compared to the paternal genotype frequencies under a further assumption of 
mating symmetry in the source population [17]. The maternal and offspring log-additive 
RRs were calculated simultaneously and thus are mutually adjusted. Missing parent 
genotypes can be accounted for with the expectation-maximization algorithm, which 
maximizes the observed-data likelihood by fractionally assigning incomplete triads into their 
data-compatible cells on the basis of the current parameter estimates, and then repeating the 
calculations iteratively up to convergence and maximization of the likelihood [27].
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For the stratified analysis, the offspring and maternal genetic models were separately fit for 
each prognostic COG risk-classification and offspring age at diagnosis dichotomized at 1 
year with separate mating types allowed within each stratum. This age dichotomy represents 
the two peaks in the neuroblastoma age at diagnosis distribution, and potentially corresponds 
to differences in etiology.
The gene-environment interaction model is an extension of the genetic only model with an 
additional term for the interaction of the offspring or maternal genotype and maternal 
vitamin intake [25]. This model allows genotypic RRs to differ across levels of vitamin 
intake. The main genotype effects were coded co-dominantly, while the interaction term is 
fit additively to enhance power. If interaction terms were significant after multiple testing 
correction, then the interaction model was refit co-dominantly to characterize the interaction 
in a less constrained way.
All p-values were corrected for the number of tests by false discovery rate (FDR) [28]. 
Results were considered significant if the FDR-corrected Q-value was less than 0.2. All 
estimated RRs are presented in relation to the minor allele at the specified SNP.
COG/CHOP Replication Study
We were able to provide replication of our findings for offspring genotypes using 
genotyping data from an ongoing GWA study. [29] Here, we conducted a GWA case-control 
study with 2101 neuroblastoma cases and 4202 healthy controls, with both sets of European-
American ancestry. Information on this study has been described elsewhere [29]. Briefly, the 
cases were diagnosed with neuroblastoma and identified through the Neuroblastoma Bio-
repository maintained by the COG, which collects germline and tumor specimens at the time 
of diagnosis. Controls with no known medical disorder were recruited from multiple sites 
within the CHOP Health Care Network. Cases enrolled in NENA were excluded from this 
cohort, resulting in 2,052 cases and 4,104 matched controls.
Imputation was performed on all case-control GWA data with IMPUTE2 using the world-
wide 1000 Genomes Project Phase Release 3 data as reference [30]. SNPs with an info score 
less than 0.8 were excluded. The same SNPs used for the NENA case-parent analysis 
(N=783) were tested for case-control association with neuroblastoma using SNPTEST under 
an additive model [31]. About a third (n=264) of the NENA SNPs required imputation for 
the COG/CHOP replication study. Odds ratios (ORs) were FDR-corrected and compared 
with the RRs from NENA study.
Sensitivity Analysis
Since many women increase dairy consumption and decrease fish consumption during 
pregnancy, and both are rich in choline, we performed sensitivity analyses. The 
questionnaire asked if women during that pregnancy had changed their intake of foods prone 
to change, including dairy and fish [32]. The mothers were asked if during pregnancy intake 
had been “Much less than it is now”, “Somewhat less than it is now”, “Same as it is now”, 
“Somewhat more than it is now”, and “Much more than it is now”.
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Choline levels were manually changed for women who reported having increased dairy 
consumption and decreased fish consumption during pregnancy. We calculated the average 
amount fish and dairy contributes to choline in NENA, 8.55 mg. Choline levels for mothers 
who reported their fish consumption during the pregnancy had been “much less than it is 
now” were decreased by 8.55 mg, resetting negative values to 0. For mothers who reported 
their dairy consumption during the pregnancy had been “much more than it is now”, their 
choline levels were increased by 73.87 mg, the average amount of choline. After this choline 
intake adjustment, choline was then dichotomized at the 25th percentile and the gene-
environment model was fit again.
Since women who breastfeed are advised to consume more calories, which alters current 
nutrient intake, additional sensitivity analyses were done excluding breastfeeding women.
Results
Descriptive Statistics
Table 1 describes the demographics of our analytic sample of families (465 triads and 98 
dyads). The mean age at diagnosis for the offspring was 1.7 years. As expected, the age at 
diagnosis differed across COG risk-classifications (p-value<0.001); the high-risk 
classification had the oldest mean age at diagnosis (2.6 years). This study included more 
male cases (53.6%) than female cases. This male excess was similar across COG risk-
classification groups except for the low-risk classification (52.4% females). The 
predominant maternal race was white (84.8%). Almost 60% of mothers (N=349) reported 
using prenatal vitamin supplementation 1 month before conception (Table 2).
Folate
We found no significant associations between folate-related maternal and offspring SNPs 
and neuroblastoma overall, or when stratified by COG risk-classification or offspring age at 
diagnosis (Supplemental table S1 and S2).
We observed no significant gene-environment interaction in relation to maternal or offspring 
genotypes for maternal vitamin supplementation 1 month pre-pregnancy or for maternal 
dietary folic acid or total folate intake. Results from the total exposure analysis combining 
prenatal vitamins and diet were also non-significant.
Choline
We found no significant associations for maternal or offspring choline SNPs, either overall 
or stratified by risk-classification or offspring age at diagnosis.
For the gene-choline interaction, we observed two significant log-additive interaction p-
values for the 25th percentile in maternal choline consumption with the offspring SNP 
rs1738575 in MTHFD1L (interaction p-value<0.001; Q-value=0.076), and with the 
offspring SNP rs9966612 near TYMS (interaction p-value<0.001; Q-value=0.140). We refit 
the interaction model co-dominantly to provide allele-count-specific point estimates, 
resulting in wider confidence intervals due to the rarity of homozygotes. For mothers below 
the 25th percentile of choline consumption (Figure 2), offspring with the G allele of 
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rs1738575 (MTHFD1L) were at increased risk of neuroblastoma (RR for G/C vs. C/C: 1.92, 
95% CI: 1.12–3.31; RR for G/G vs. C/C: 2.82, 95% CI: 1.46–5.46), compared to a null 
association when maternal choline was above 25th percentile (RR for G/C vs. C/C: 1.03, 
95% CI: 0.77–1.38; RR for G/G vs. C/C: 0.62, 95% CI: 0.31–1.27). We found offspring with 
the A allele in the SNP rs9966612 (TYMS) had lower risk of neuroblastoma (Figure 3) 
when maternal choline consumption was below the 25th percentile (RR for A/G versus G/G: 
0.46, 95% CI: 0.30–0.70; RR for A/A versus G/G: 0.5, 95% CI: 0.21–1.21), with both lower 
than the relative risks among triads with maternal choline greater than the 25th percentile 
(RR for A/G versus G/G: 1.35, 95% CI: 1.04–1.75; RR for A/A versus G/G: 1.08, 95% CI: 
0.31–3.75).
When choline was dichotomized at the Adequate Intake level (425 mg), the log-additive 
interaction was significant for the offspring SNP rs10489810 located in SLC44A3 
(interaction p-value<0.001; Q-value=0.173). Among mothers with below Adequate Intake of 
choline consumption, we found offspring with one T allele had little evidence for association 
(RR T/A vs. A/A: 0.91, 95% CI: 0.71–1.17) while those with 2 T alleles had an inverse 
association (RR T/T vs. A/A: 0.43, 95% CI: 0.26–0.70). Among mothers with above 
Adequate Intake level of choline, offspring with 1 T allele and those with 2 T alleles had an 
increased risk (RR T/A vs. A/A: 2.00, 95% CI: 1.11–3.60; RR T/T vs. A/A: 2.85, 95% CI: 
0.98–8.30) of neuroblastoma.
Replication Study
Maternal genotyping and questionnaire data were not available from the replication study, 
thus only offspring genetic results were compared. No offspring variants in NENA were 
significant. A few COG/CHOP replication study results were significant (Supplemental table 
S2). However, the results from NENA for these SNPs were not also significant and the RRs 
were not directionally consistent between studies.
Sensitivity Analysis
Among women who were below the 25th percentile for choline, 10 mothers increased dairy 
consumption and 2 increased fish consumption during pregnancy. Among women with 
greater than the 25th percentile for choline consumption, only 8 decreased dairy 
consumption but 83 decreased fish consumption during pregnancy. After changing the 
choline intake for these families, both alleles for rs10489810 and rs9966612 remained 
significant (Supplemental table S3) and the point estimates changed little. We also found a 
significant interaction with offspring alleles in rs9478157 and rs1052751, neither of which 
had previously been significant.
We found no new significant results when women who were breastfeeding were excluded 
(N=46). The previously identified gene-choline interactions for offspring SNPs rs10489810 
and rs9966612 remained nominally significant and were directionally unchanged.
Discussion
These analyses were motivated by prior epidemiologic evidence suggesting inadequate 
maternal consumption of folate, folic acid, and choline during pregnancy increases the risk 
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of the unborn child subsequently developing neuroblastoma. Although SNPs within the one-
carbon metabolism pathway have been previously associated with birth defects and 
childhood cancers, our study suggests SNPs from either choline or folate-related genes were 
not associated with neuroblastoma overall, within COG risk-classification categories, or by 
categories defined by age at diagnosis [33–36]. While significant SNPs were found in the 
COG/CHOP case-control replication study, those SNPs were not significant and were not 
directionally consistent with NENA results. The gene-environment interaction results 
suggest gene variants in choline pathways be modified by choline intake; however, since the 
identified SNPs lie within non-coding regions, the exact implications of these associations 
are unclear.
We found no offspring or maternal associations for the SNPs that were selected because they 
had previously been associated with cancer or birth defects. MTHFR 667C>T (rs1801133), 
one of the most highly studied variants with known functional effects on one-carbon 
metabolism, [37–39] had a null offspring association (RR: 0.99, 95% CI: 0.84–1.19) and a 
weak maternal association (RR: 1.16, 95% CI: 0.97–1.38). Two previous studies of 
candidate SNPs from folate-related genes identified SLC19A1 80G>A (rs1051266) as 
positively associated with neuroblastoma in Brazil [40, 41]. Montalvão-de-Azevedo et al. 
found maternal carriers of the G had 3 times the risk of offspring with neuroblastoma and 
offspring carriers had approximately 2.5 times the risk, which was replicated by de Miranda 
et al. [40, 41]. In NENA, we found no association (Maternal RR: 1.12, 95% CI: 0.96–1.32; 
offspring log-additive RR: 0.94, 95% CI: 0.79–1.11). The inconsistent findings may be due 
to chance, differences in ancestry and the associated linkage with a causative SNP, 
confounding by maternal genotype, or possibly different dietary and vitamin 
supplementation intake patterns in Brazil.
We found significant gene-choline interaction for two offspring SNPs, rs1738575 and 
rs9966612, respectively located in an intron of MTHFD1L and upstream from TYMS. 
MTHFD1L is involved in tetrahydrofolate conversion in the mitochondria during one-carbon 
metabolism [11]. SNP rs9966612 is about 8 kbp upstream from TYMS but within the intron 
of CLUL1 and 500 bp downstream from TYMSOS. However, there is no compelling 
evidence either TYMSOS or CLUL1 is related to neuroblastoma development [42]. Since 
we used haplotype tagging, these SNPs could be in LD with the casual SNP. To further 
explore correlated SNPs, we used SNP Annotation and Proxy Search developed by the 
Broad Institute to find SNPs in high LD (r2>0.8) based on the 1000 Genome CEU 
population [43]. SNPs in high LD with rs1738575 and rs9966612 have not previously been 
associated with disease. Choline is involved with one-carbon metabolism and both TYMS 
and MTHFD1L encode proteins essential to one-carbon metabolism [44]. The functionality 
of these variants is known.
When choline was dichotomized at the Adequate Intake level, we found one additional 
interacting offspring SNP, which appeared to increase the risk of neuroblastoma among 
those above the Adequate Intake level but decrease risk among offspring below. The 
offspring SNP rs10489810 is located within an intron of SLC44A3, a choline transporter. 
However, SNPs in SLC44A3 and those in high LD with rs10489810 have an unknown 
functional impact and have not previously been associated with any disease.
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The present study has some limitations. Neuroblastoma is too rare to be studied 
prospectively and our assessment of pre-pregnancy maternal diet was necessarily 
retrospective. Studies have demonstrated that maternal preconception nutritional status is 
critical for early fetal development but the critical etiologic window specific to 
neuroblastoma is nonetheless unknown [45]. The mothers in NENA completed the FFQ 
shortly after enrollment (2 months to 9 years after the offspring birth date). This assessment 
of diet more likely mirrors pre-pregnancy diet rather than early pregnancy, when mothers 
may have changed diet due to morning sickness [46]. Moreover, the FFQ occurred during a 
time when their child was suffering with a critical illness or may have died, leading to the 
potential for substantial disruption of their routine eating patterns. However, nutrient levels 
of folic acid, folate and choline from diet did not significantly differ by risk-classification or 
vital status, suggesting that nutrient levels do not differ by severity of disease. Furthermore, 
our sensitivity analysis revealed the FDR-significant SNPs for gene-choline interaction were 
stable to differences in the estimation of choline levels related to reported changes in fish 
and dairy consumption during pregnancy. The sample studied in NENA were mostly white 
and highly educated (over 50% graduated college), and thus had greater rates of vitamin 
consumption and nutrient intake compared to the general population in the United States 
[47]. Although the nature of our study sample does not affect the validity of the study, it 
could reduce generalizability and introduces the possibility we are not capturing the “high-
risk” population that could benefit the most from intervention.
The study has multiple strengths. This is the largest study conducted with both genetic and 
maternal questionnaire data to allow for the study of gene-environment interaction for 
candidate genes with neuroblastoma. The case-parent triad approach eliminates the need for 
a control group, a logistical and validity challenge for a North America-wide study. 
Additionally, the case-parent triad design is robust against bias due to population 
stratification and self-selection based on ethnicity. The case-parent triad approach also 
allows for the estimation of maternal RRs, which is especially important for diseases that 
can originate in utero. Mating symmetry (i.e. a genotype is over represented in either the 
mother or father not due to the disease state of the offspring) could be violated when 
assessing maternal associations. However, the null findings for maternal effects argue for 
symmetry for the studied SNPs. We also employed the use of an independent replication 
study that provided additional evidence for the robustness of our null results for offspring 
SNPs and neuroblastoma. Although a few of the CHOP/COG replication results were 
significant, they were not directionally consistent with NENA results. This is most likely to 
chance, but could also be due to differences LD patterns [48].
This study suggests that maternal and offspring SNPs in folate and choline-related genes are 
not strongly associated with neuroblastoma. Further, gene-environment interactions were not 
identified for maternal vitamin supplementation or total folate or folic acid intake from diet, 
suggesting there is no appreciable modification of effects of SNPs near folate genes by 
maternal diet or vitamin supplementation. Our suggestive diet-by-SNP interactions for SNPs 
related to the choline pathway warrant further study.
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Figure 1. 
Flowchart for genetic and questionnaire quality control for triads and dyads.
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Figure 2. 
A) Offspring and B) maternal MTHFD1L (rs1738575)-choline interaction modeled co-
dominantly with maternal choline consumption dichotomized at the 25th percentile
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Figure 3. 
A) Offspring and B) maternal TYMS (rs9966612)-choline interaction modeled co-
dominantly with maternal choline consumption dichotomized at the 25th percentile
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Table 2
Descriptive statistics of maternal usual dietary nutrient levels and supplemental pre-pregnancy vitamin 
consumption
N %
Vitamin use 1 month pre-pregnancy
Yes 349 59.4
No 239 40.6
Missing 36 --
N Median (IQR)
Choline (mg) 559 279.78 (208.28–372.39)
Folate (µg Dietary Folate Equivalent) 559 511.29 (389.71–698.35)
Folic Acid (µg) 559 162.11 (100.69–233.79)
IQR: Interquartile Range
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